...
首页> 外文期刊>Journal of hypertension >Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population.
【24h】

Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population.

机译:为什么在一般人群中,经过治疗的高血压患者的心血管死亡率要高于相同年龄的受试者。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE The aim of the present study was to assess whether increased cardiovascular mortality in treated hypertensives could be explained by high blood pressure levels, or by the presence of associated risk factors and/or associated diseases.DESIGN The study sample consisted of 8893 treated hypertensive men and women from the Investigations Preventives et Cliniques cohort, and 25 880 gender-matched and age-matched untreated subjects from the same cohort. Vital status was obtained for an 8-12 year period.RESULTS Treated hypertensive subjects had higher systolic blood pressure (SBP) (+ 15 mmHg) and higher diastolic blood pressure (+ 9 mmHg), and a higher prevalence of associated risk factors and diseases. Treated hypertensives compared with untreated subjects presented a two-fold increase in the risk ratio (RR) for cardiovascular mortality [RR, 1.96; 95% confidence interval (CI), 1.74-2.22] and coronary mortality (RR, 1.99; 95% CI, 1.63-2.44). Adjustment for unmodifiable risk factors decreased the excess cardiovascular risk observed in treated subjects only slightly: RR, 1.77; 95% CI, 1.56-2.00 for cardiovascular mortality; and RR, 1.76; 95% CI, 1.44-2.16 for coronary mortality. After additional adjustment for modifiable associated risk factors, the increased mortality in treated subjects persisted: RR, 1.52; 95% CI, 1.33-1.74 for cardiovascular mortality; and RR, 1.49; 95% CI, 1.19-1.86 for coronary mortality. Only after additional adjustment for SBP were cardiovascular mortality and coronary mortality similar in the two groups of subjects: RR, 1.06; 95% CI, 0.92-1.23; and RR, 1.06; 95% CI, 0.85-1.35, respectively.CONCLUSIONS The increased cardiovascular mortality in treated hypertensive subjects as compared with untreated subjects is mainly due to high SBP levels under treatment. This result suggests that the excess risk found in treated hypertensives may be drastically reduced if SBP were brought under control.
机译:目的本研究的目的是评估是否可以通过高血压或存在相关危险因素和/或相关疾病来解释高血压病患者的心血管疾病死亡率升高。设计本研究样本由8893名高血压病患者组成和来自“调查预防与临床研究”队列的女性,以及来自同一队列的25880名性别匹配和年龄匹配的未治疗受试者。结果为8-12年的生命状态。结果治疗的高血压受试者的收缩压(SBP)较高(+ 15 mmHg)和舒张压(+ 9 mmHg)较高,相关危险因素和疾病的患病率较高。与未治疗的受试者相比,治疗的高血压患者的心血管死亡风险比(RR)增长了两倍[RR,1.96; 95%置信区间(CI)为1.74-2.22]和冠心病死亡率(RR为1.99; 95%CI为1.63-2.44)。调整不可改变的危险因素仅能轻微降低在治疗受试者中观察到的过度心血管风险:RR,1.77;正常人,1.77。 95%CI,心血管死亡率为1.56-2.00;和RR,1.76; 95%CI,冠状动脉死亡率为1.44-2.16。在对可调整的相关危险因素进行额外调整后,治疗受试者的死亡率持续上升:RR为1.52; 95%CI,心血管死亡率为1.33-1.74;和RR,1.49; 95%CI,冠状动脉死亡率为1.19-1.86。只有在对SBP进行额外调整之后,两组受试者的心血管死亡率和冠状动脉死亡率才相似:RR,1.06; RR,1.06。 95%CI,0.92-1.23;和RR,1.06;结论CI分别为95%CI,0.85-1.35。结论与未治疗的受试者相比,治疗的高血压受试者的心血管死亡率增加主要是由于治疗中SBP水平较高。该结果表明,如果控制SBP,可以大大降低在治疗的高血压中发现的过量风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号